Shareholders revolt over Glaxo chief's pay

Drugs giant GlaxoSmithKline was today poised for what could be the biggest shareholder rebellion over “fat cat” pay ever seen in the UK.

An outright majority of shareholders will fail to back the company’s position in a vote over boardroom pay at its annual general meeting tomorrow, according to reports.